Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions

Cell Death and Disease

Volumn 2, Issue 9, 2011, Pages

  Lathia, J D ^a   Hitomi, M ^a   Gallagher, J ^a   Gadani, S P ^a   Adkins, J ^b   Vasanji, A ^a   Liu, L ^a   Eyler, C E ^c   Heddleston, J M ^a   Wu, Q ^a   Minhas, S ^a   Soeda, A ^d,g   Hoeppner, D J ^e   Ravin, R ^e   McKay, R D G ^e   McLendon, R E ^c   Corbeil, D ^f   Chenn, A ^b   Hjelmeland, A B ^a   Park, D M ^d,g   Rich, J N ^a   more..

^a LERNER RESEARCH INSTITUTE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^g UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Asymmetric cell division; Cancer stem cell; Glioma

Indexed keywords

CD133 ANTIGEN; CELL MARKER; GROWTH FACTOR;

ARTICLE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL DIVISION; CELL EXPANSION; CELL LINEAGE; CELL RENEWAL; CONTROLLED STUDY; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE CELL ANALYSIS;

ANTIGENS, CD; CELL DIVISION; CELL LINEAGE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GLIOMA; GLYCOPROTEINS; HUMANS; LAMININ; MITOSIS; NEOPLASTIC STEM CELLS; PEPTIDES;

EID: 80053430963     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2011.80     Document Type: Article

References (31)

1. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTCNCIC trial. Lancet Oncol 2009; 10: 459-466.
2. Anderson K, Lutz C, van Delft FW, Bateman CM, Guo Y, Colman SM et al. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature 2011; 469: 356-361.
3. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821-5828. (Pubitemid 37187480)
4. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401. (Pubitemid 39551674)
5. Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 2002; 39: 193-206.
6. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004; 64: 7011-7021. (Pubitemid 39331011)
7. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444: 756-760. (Pubitemid 44949604)
8. Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006; 5: 67.
9. Doe CQ. Neural stem cells: balancing self-renewal with differentiation. Development 2008; 135: 1575-1587. (Pubitemid 351895487)
10. Kosodo Y, Roper K, Haubensak W, Marzesco AM, Corbeil D, Huttner WB. Asymmetric distribution of the apical plasma membrane during neurogenic divisions of mammalian neuroepithelial cells. EMBO J 2004; 23: 2314-2324. (Pubitemid 38833240)
11. Ravin R, Hoeppner DJ, Munno DM, Carmel L, Sullivan J, Levitt DL et al. Potency and fate specification in CNS stem cell populations in vitro. Cell Stem Cell 2008; 3: 670-680.
12. Wu M, Kwon HY, Rattis F, Blum J, Zhao C, Ashkenazi R et al. Imaging hematopoietic precursor division in real time. Cell Stem Cell 2007; 1: 541-554. (Pubitemid 350056405)
13. Rieger MA, Hoppe PS, Smejkal BM, Eitelhuber AC, Schroeder T. Hematopoietic cytokines can instruct lineage choice. Science 2009; 325: 217-218.
14. Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, Russell R et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 2009; 4: 568-580.
15. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992; 255: 1707-1710.
16. Li Z, Wang H, Eyler CE, Hjelmeland AB, Rich JN. Turning cancer stem cells inside out: an exploration of glioma stem cell signaling pathways. J Biol Chem 2009; 284: 16705-16709.
17. Karbanova J, Missol-Kolka E, Fonseca AV, Lorra C, Janich P, Hollerova H et al. The stem cell marker CD133 (Prominin-1) is expressed in various human glandular epithelia. J Histochem Cytochem 2008; 56: 977-993.
18. Lathia JD, Gallagher J, Heddleston JM, Wang J, Eyler CE, Macswords J et al. Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 2010; 6: 421-432.
19. Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, McLendon RE et al. Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res 2008; 68: 6043-6048.
20. Son MJ, Woolard K, Nam DH, Lee J, Fine HA. SSEA-1 is an enrichment marker for tumorinitiating cells in human glioblastoma. Cell Stem Cell 2009; 4: 440-452.
21. Roper K, Corbeil D, Huttner WB. Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat Cell Biol 2000; 2: 582-592.
22. Corbeil D, Marzesco AM, Wilsch-Brauninger M, Huttner WB. The intriguing links between prominin-1 (CD133), cholesterol-based membrane microdomains, remodeling of apical plasma membrane protrusions, extracellular membrane particles, and (neuro)epithelial cell differentiation. FEBS Lett 2010; 584: 1659-1664.
23. Bauer N, Fonseca AV, Florek M, Freund D, Jaszai J, Bornhauser M et al. New insights into the cell biology of hematopoietic progenitors by studying prominin-1 (CD133). Cells Tissues Organs 2008; 188: 127-138. (Pubitemid 351962236)
24. Di Marcotullio L, Ferretti E, Greco A, De Smaele E, Po A, Sico MA et al. Numb is a suppressor of Hedgehog signalling and targets Gli1 for Itch-dependent ubiquitination. Nat Cell Biol 2006; 8: 1415-1423. (Pubitemid 44835117)
25. McGill MA, Dho SE, Weinmaster G, McGlade CJ. Numb regulates post-endocytic trafficking and degradation of Notch1. J Biol Chem 2009; 284: 26427-26438.
26. Chen R, Nishimura MC, Bumbaca SM, Kharbanda S, Forrest WF, Kasman IM et al. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell 2010; 17: 362-375.
27. Weigmann A, Corbeil D, Hellwig A, Huttner WB. Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci USA 1997; 94: 12425-12430. (Pubitemid 27492544)
28. Harder T, Scheiffele P, Verkade P, Simons K. Lipid domain structure of the plasma membrane revealed by patching of membrane components. J Cell Biol 1998; 141: 929-942. (Pubitemid 28243961)
29. Seveau S, Eddy RJ, Maxfield FR, Pierini LM. Cytoskeleton-dependent membrane domain segregation during neutrophil polarization. Mol Biol Cell 2001; 12: 3550-3562. (Pubitemid 33108486)
30. Freeman MR, Cinar B, Kim J, Mukhopadhyay NK, Di Vizio D, Adam RM et al. Transit of hormonal and EGF receptor-dependent signals through cholesterol-rich membranes. Steroids 2007; 72: 210-217. (Pubitemid 46273499)
31. Patra SK. Dissecting lipid raft facilitated cell signaling pathways in cancer. Biochim Biophys Acta 2008; 1785: 182-206.